Thomas Kicmal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Kicmal has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Amedee Des Georges
Department of Molecular Pathobiology, College of Dentistry, New York University, New York, USA
1 shared publication - Anne Moscona
Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons
1 shared publication - Emily Armbruster
CUNY Advanced Science Research Center 2 Structural Biology Initiative City University of New York, New York, New York
1 shared publication - Gaël McGill
Digizyme Inc., Brookline, MA, USA
1 shared publication - Gillian Zipursky
Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
1 shared publication Jennifer Drew-Bear
Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA
1 shared publication
Latest Publications
- Open Access
- 19 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (33) , eabo3153
Intermediates in SARS-CoV-2 spike–mediated cell entry
SARS-CoV-2 cell entry is completed after viral spike (S) protein–mediated membrane fusion between viral and host cell membranes. Stable prefusion and postfusion S structures have been resolved by cryo–electron microscopy and cryo–electron tomography, but the refolding intermediates on the fusion pathway are transient and have not been examined. We used an antiviral lipopeptide entry inhibitor to arrest S protein refolding and thereby capture intermediates as S proteins interact with hACE2 and fusion-activating proteases on cell-derived target membranes. Cryo–electron tomography imaged both extended and partially folded intermediate states of S2, as well as a novel late-stage conformation on the pathway to membrane fusion. The intermediates now identified in this dynamic S protein–directed fusion provide mechanistic insights that may guide the design of CoV entry inhibitors.
- 19 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (33) , eabo3153
Open AccessIntermediates in SARS-CoV-2 spike–mediated cell entry
SARS-CoV-2 cell entry is completed after viral spike (S) protein–mediated membrane fusion between viral and host cell membranes. Stable prefusion and postfusion S structures have been resolved by cryo–electron microscopy and cryo–electron tomography, but the refolding intermediates on the fusion pathway are transient and have not been examined. We used an antiviral lipopeptide entry inhibitor to arrest S protein refolding and thereby capture intermediates as S proteins interact with hACE2 and fusion-activating proteases on cell-derived target membranes. Cryo–electron tomography imaged both extended and partially folded intermediate states of S2, as well as a novel late-stage conformation on the pathway to membrane fusion. The intermediates now identified in this dynamic S protein–directed fusion provide mechanistic insights that may guide the design of CoV entry inhibitors.